Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

about

In vivo genome editing partially restores alpha1-antitrypsin in a murine model of AAT deficiency.Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties.Alpha-1 antitrypsin deficiency: outstanding questions and future directions.

P2860

Q52431137-41A77FFC-7CA0-40CE-B621-2439178E2FCE Q55438350-ADD69F0D-5D2B-4A42-88AF-E2A05EB50687 Q55666746-B2C03FE1-309A-4F3F-92F0-48E87C3058A3

P2860

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Item

http://www.wikidata.org/entity/Q38937862

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

@en

type

Item

label

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

@en

prefLabel

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

@en

P1476

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

@en

P2093

Maria J Chiuchiolo

http://www.w3.org/2001/XMLSchema#string

Ronald G Crystal

http://www.w3.org/2001/XMLSchema#string

P2860

α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8

Expanding the clinical indications for α(1)-antitrypsin therapy

Active trafficking of alpha 1 antitrypsin across the lung endothelium

Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro.

Survival in severe alpha-1-antitrypsin deficiency (PiZZ).

Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease

Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs.

Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions.

P304

S352-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1513/ANNALSATS.201506-344KV

http://www.w3.org/2001/XMLSchema#string

P478

13 Suppl 4

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27564673

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

5059492

http://www.w3.org/2001/XMLSchema#string

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

about

P2860

P2860

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932